Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Intangibles (2018 - 2020)

Collegium Pharmaceutical has reported Change in Intangibles over the past 2 years, most recently at $1.4 million for Q2 2020.

  • Quarterly results put Change in Intangibles at $1.4 million for Q2 2020, changed N/A from a year ago — trailing twelve months through Dec 2020 was $368.2 million (changed N/A YoY), and the annual figure for FY2020 was $368.2 million, changed.
  • Change in Intangibles for Q2 2020 was $1.4 million at Collegium Pharmaceutical, down from $366.8 million in the prior quarter.
  • Over the last five years, Change in Intangibles for COLL hit a ceiling of $366.8 million in Q1 2020 and a floor of $116000.0 in Q2 2018.